全文获取类型
收费全文 | 19451篇 |
免费 | 1924篇 |
国内免费 | 529篇 |
专业分类
耳鼻咽喉 | 76篇 |
儿科学 | 487篇 |
妇产科学 | 318篇 |
基础医学 | 1240篇 |
口腔科学 | 506篇 |
临床医学 | 4295篇 |
内科学 | 7965篇 |
皮肤病学 | 117篇 |
神经病学 | 317篇 |
特种医学 | 623篇 |
外国民族医学 | 17篇 |
外科学 | 1390篇 |
综合类 | 2521篇 |
现状与发展 | 3篇 |
预防医学 | 516篇 |
眼科学 | 82篇 |
药学 | 622篇 |
17篇 | |
中国医学 | 167篇 |
肿瘤学 | 625篇 |
出版年
2024年 | 18篇 |
2023年 | 360篇 |
2022年 | 467篇 |
2021年 | 757篇 |
2020年 | 1092篇 |
2019年 | 926篇 |
2018年 | 841篇 |
2017年 | 643篇 |
2016年 | 655篇 |
2015年 | 744篇 |
2014年 | 1330篇 |
2013年 | 1271篇 |
2012年 | 1007篇 |
2011年 | 1180篇 |
2010年 | 902篇 |
2009年 | 912篇 |
2008年 | 858篇 |
2007年 | 948篇 |
2006年 | 858篇 |
2005年 | 768篇 |
2004年 | 597篇 |
2003年 | 522篇 |
2002年 | 416篇 |
2001年 | 430篇 |
2000年 | 399篇 |
1999年 | 325篇 |
1998年 | 326篇 |
1997年 | 316篇 |
1996年 | 248篇 |
1995年 | 272篇 |
1994年 | 208篇 |
1993年 | 217篇 |
1992年 | 204篇 |
1991年 | 153篇 |
1990年 | 102篇 |
1989年 | 73篇 |
1988年 | 79篇 |
1987年 | 82篇 |
1986年 | 64篇 |
1985年 | 76篇 |
1984年 | 65篇 |
1983年 | 53篇 |
1982年 | 57篇 |
1981年 | 27篇 |
1980年 | 20篇 |
1979年 | 15篇 |
1978年 | 8篇 |
1977年 | 5篇 |
1976年 | 6篇 |
1975年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
《The Journal of thoracic and cardiovascular surgery》2023,165(1):301-326
ObjectiveThe use of mechanical circulatory support (MCS) in lung transplantation has been steadily increasing over the prior decade, with evolving strategies for incorporating support in the preoperative, intraoperative, and postoperative settings. There is significant practice variability in the use of these techniques, however, and relatively limited data to help establish institutional protocols. The objective of the AATS Clinical Practice Standards Committee (CPSC) expert panel was to review the existing literature and establish recommendations about the use of MCS before, during, and after lung transplantation.MethodsThe AATS CPSC assembled an expert panel of 16 lung transplantation physicians who developed a consensus document of recommendations. The panel was broken into subgroups focused on preoperative, intraoperative, and postoperative support, and each subgroup performed a focused literature review. These subgroups formulated recommendation statements for each subtopic, which were evaluated by the entire group. The statements were then developed via discussion among the panel and refined until consensus was achieved on each statement.ResultsThe expert panel achieved consensus on 36 recommendations for how and when to use MCS in lung transplantation. These recommendations included the use of veno-venous extracorporeal membrane oxygenation (ECMO) as a bridging strategy in the preoperative setting, a preference for central veno-arterial ECMO over traditional cardiopulmonary bypass during the transplantation procedure, and the benefit of supporting selected patients with MCS postoperatively.ConclusionsAchieving optimal results in lung transplantation requires the use of a wide range of strategies. MCS provides an important mechanism for helping these critically ill patients through the peritransplantation period. Despite the complex nature of the decision making process in the treatment of these patients, the expert panel was able to achieve consensus on 36 recommendations. These recommendations should provide guidance for professionals involved in the care of end-stage lung disease patients considered for transplantation. 相似文献
2.
Elin Rosen-Wetterholm Oscar Cavefors Björn Redfors Sven-Erik Ricksten Elmir Omerovic Christian L. Polte Jonatan Oras 《Acta anaesthesiologica Scandinavica》2023,67(6):746-754
Introduction
Left ventricular (LV) dysfunction is estimated to occur in 10%–25% of the general intensive care unit (ICU) population and is frequently seen as regional wall motion abnormalities (RWMAs). Although RWMA is mostly attributed to myocardial ischemia or infarction, some studies have suggested that nonischemic RWMA might also be prevalent. We sought to establish that RWMA can be seen in critically ill patients with normal coronary arteries and to explore reasons for RWMA in this population.Methods
In this retrospective study, data from the hospital angiography register and the ICU register were collated between 2012 and 2019. Patients were identified who underwent angiography in conjunction with their ICU stay and had RWMA on echocardiography. Patients were divided into either those with non-obstructed or those with obstructed coronary arteries. Cardiac magnetic resonance imaging (cMRI) examinations were reviewed if they had been performed on patients with non-obstructed coronaries.Results
We identified 53 patients with RWMA and non-obstructed coronary arteries and 204 patients with RWMA and obstructed coronary arteries. Patients with non-obstructed coronary arteries were more often female, younger, and had fewer cardiovascular risk factors. They less commonly had ST elevation, but more frequently had T-wave inversion or serious arrhythmias. Troponin levels were higher in patients with obstructed coronary arteries, but NT-proBNP was similar between the groups. There were no differences in risk-adjusted 90-day mortality between patients with non-obstructed versus obstructed coronary arteries (OR 1.21, [95% CI 0.56–2.64], p = .628). In those with non-obstructed coronary arteries, follow-up echocardiography was available for 38 patients, of whom 30 showed normalization of cardiac function. Of the 14 patients with non-obstructed coronary arteries on whom cMRI was performed, 7 had a tentative diagnosis of Takotsubo syndrome or myocardial stunning; 4 had a myocardial infarction (preexisting in 3 cases); 1 patient had acute myocarditis; 1 patient had post-myocarditis; and 1 patient was diagnosed with dilated cardiomyopathy.Conclusion
RWMA can be seen to occur in critically ill patients in the absence of coronary artery obstruction. Several conditions can cause regional hypokinesia, and cMRI is useful to evaluate the underlying etiology. 相似文献3.
目的 建立一种能够快速鉴定人参和西洋参的双重实时荧光PCR方法。方法 通过对人参属及其近似种基因序列的分析比对,设计特异性的引物探针,建立双重实时荧光PCR检测方法。PCR反应体系为Premix Ex Taq (Probe qPCR) 10 μL,人参上下游引物各0.5 μL,西洋参上下游引物各0.3 μL,人参与西洋参特异性探针各0.4 μL,DNA模板2 μL,灭菌去离子水补至20 μL。反应条件为95℃预变性30 s;然后以95℃变性5 s,60℃退火延伸30 s进行40个循环。应用该方法测试了27份DNA样品,包括7份人参、6份西洋参、4份人参与西洋参混合样、10份其他人参属样品及其他常见中药材样品的DNA,以确定该方法的特异性。将人参与西洋参样品DNA混合后10倍稀释成不同浓度后进行检测,用以确定该方法的灵敏度。结果 人参及西洋参样品均在特定的荧光通道下出现典型的阳性扩增曲线,人参与西洋参混合样品均同时出现两条阳性扩增曲线,其它对照样品及空白对照均没有出现阳性扩增曲线。灵敏度检测结果显示该方法检测人参及西洋参的最低检测限均为2 pg DNA/反应。结论 本实验建立的双重实时荧光PCR方法能够同时快速、准确、灵敏地鉴别出人参和西洋参。 相似文献
4.
5.
6.
7.
8.
9.
10.